Home ›
Organizations ›
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
MN · Medical Research · EIN 411677920
34
Executives Disclosed
$54.7M
Annual Revenue
$75.5M
Total Assets
2.1:1
Internal Pay Ratio
HENNEPIN HEALTHCARE RESEARCH INSTITUTE has 34 executives with disclosed compensation. The highest-paid executive, Andrew Schmidt Md (DIRECTOR/PHYSICIAN (UNTIL 6/24)), received peak total compensation of $735,739. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Andrew Schmidt | DIRECTOR/PHYSICIAN (UNTIL 6/24) | $736K | $661K | 2023–2024 | 9.8x |
| Derrick Hollings Inactive | DIRECTOR/HHS - CFO (UNTIL 09/23) | $723K | $636K | 2021–2023 | 9.6x |
| Derrick Hollings | Director/CFO | $668K | $668K | 2017–2020 | 8.9x |
| Daniel Hoody | DIRECTOR/HHS - CMO (UNTIL 09/23) | $660K | $522K | 2020–2023 | 8.8x |
| William Heegaard | Director/CCO | $602K | $602K | 2016–2019 | 8x |
| Michael Puskarich | DIRECTOR/PHYSICIAN | $580K | $574K | 2023–2024 | 7.7x |
| James R Miner | DIRECTOR/PHYSICIAN (UNTIL 03/31/22) | $549K | $518K | 2019–2022 | 7.3x |
| Michael Puskarich | DIRECTOR/PHYSICIAN | $546K | $546K | 2022–2022 | 7.3x |
| James Miner | Director/Physician | $541K | $541K | 2016–2017 | 7.2x |
| Meghan Walsh | DIRECTOR/HHS - CARO | $540K | $540K | 2024–2024 | 7.2x |
| Kirsten L Johansen | PRESIDENT/INVESTIGATOR | $538K | $538K | 2023–2024 | 7.2x |
| Larry Kryzaniak | Director/CFO | $512K | $512K | 2016–2016 | 6.8x |
| Theresa Pesch | HHS VP OF PHILANTHROPHY | $494K | $494K | 2020–2024 | 6.6x |
| Ajay Israni | FORMER PRESIDENT/INVESTIGATOR | $419K | $311K | 2016–2024 | 5.6x |
| Jason Baker | FORMER VICE PRESIDENT/INVESTIGATOR | $364K | $351K | 2016–2024 | 4.9x |
| Eric Ling | DIRECTOR/HHS - CHIEF OF MEDICAL OFFICER | $362K | $362K | 2024–2024 | 4.8x |
| Anne Frosch | DIRECTOR/INVESTIGATOR | $346K | $333K | 2023–2024 | 4.6x |
| David Gilbertson | PROGRAM CO-DIRECTOR | $315K | $315K | 2016–2024 | 4.2x |
| Anne Murray | FORMER SECRETARY/TREASURER/INVESTIGATOR | $291K | $260K | 2016–2024 | 3.9x |
| Rachel Nygaard | DIRECTOR/SURGERY RESEARCH | $287K | $287K | 2019–2024 | 3.8x |
| Jiannoung Liu | DIRECTOR, ANALYSIS | $260K | $260K | 2024–2024 | 3.5x |
| Jon Snyder | DIRECTOR, TRANSPLANT EPIDEMIOLOGY | $257K | $257K | 2016–2024 | 3.4x |
| Jiannong Liu | DIRECTOR, ANALYTICS | $250K | $250K | 2016–2023 | 3.3x |
| Mark Willmert Inactive | HHF/HHRI - VP OF FINANCE | $243K | $243K | 2024–2024 | 3.2x |
| Mark Willmert | HHF/HHRI- VP OF FINANCE | $230K | $258K | 2016–2023 | 3.1x |
| Mary Bergaas | VP of Operations & COO | $224K | $0 | 2016–2019 | 3x |
| Kim Miller | VP OF OPERATIONS & COO | $216K | $216K | 2019–2024 | 2.9x |
| Shuling Li | EPIDDEMIOLOGIST & BIOSTATISTICIAN | $212K | $212K | 2020–2024 | 2.8x |
| Yi Peng | DIRECTOR, ANALYTICS | $210K | $210K | 2019–2021 | 2.8x |
| Eric Weinhandl | EPIDEMIOLOGIST & BIOSTATICIAN, SR. | $204K | $204K | 2021–2021 | 2.7x |
| Raymond Sailer | Director/Finance | $190K | $190K | 2016–2019 | 2.5x |
| Mark Lesage | DIRECTOR/INVESTIGATOR | $186K | $186K | 2016–2022 | 2.5x |
| Paul Pentel | Former President/Investigator | $154K | $154K | 2016–2017 | 2x |
| Warren McKinney | DIRECTOR/VP FOR EQUITY IN RESEARCH/INVESTIGATOR | $142K | $0 | 2022–2024 | 1.9x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 14 | $279K | $547K | $3.6M |
| 2017 | 14 | $279K | $546K | $3.9M |
| 2019 | 16 | $294K | $618K | $4.4M |
| 2020 | 15 | $305K | $668K | $4.6M |
| 2021 | 15 | $302K | $615K | $4.5M |
| 2022 | 17 | $354K | $723K | $5.7M |
| 2023 | 18 | $383K | $736K | $6.5M |
| 2024 | 18 | $365K | $661K | $6.2M |
Email Alerts
Get notified about HENNEPIN HEALTHCARE RESEARCH INSTITUTE
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.